ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

In Brief: William Roper To Head Health Research Center; Announcement Of New NIH director Is Imminent

July 2, 1993

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Kennedy, Hutchison Introduce Long-Awaited Bill To Reauthorize The National Cancer Program

April 3, 2009